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Letter to the Editor re: Identifying the Carotid ‘High
Risk’ Plaque
Sir,
The article by Golledge et al.1 regarding the identifica-
tion of ‘high-risk’ carotid plaque is interesting and
raises some very important diagnostic as well as prog-
nostic issues.
Various controversies exist concerning the charac-
terization of ‘high-risk’ carotid plaques according to
their morphology as well the contents. Clinical deci-
sions, however, are still made using stenosis as the
main criterion. While a hemodynamically significant
stenosis is more likely to result in acute ischemic stroke
due to hypoperfusion, a ‘high-risk’ plaque is expected
to act as a source of cerebral emboli. In clinical practice,
both phenomena usually contribute to the acute ische-
mic stroke and often, these are not addresseddiscretely.
Ultrasound criteria for grading carotid stenosis are
well established. Although the embolic potential of
the carotid plaques should be determined by their
morphology and the contents, none of them has been
found reliably associated with stroke risk. Since the
underlying etiopathogenic mechanism is emboliza-
tion, emboli detection in the cerebral circulation by
transcranial Doppler (TCD) is essential and the quan-
titative assessment of microembolic signals should de-
termine the embolic potential of the carotid plaques.
The sensitivity of TCD, especially when performed
early after the embolic event, may be enhanced by us-
ing power M-mode (PMD) owing to its overlapping
and contiguousmultiple gates. PMD-TCD views blood
flow frommultiple vessels simultaneously and detects
a significantly larger number of microembolic signals,
resulting in an improved quantitative assessment of
the embolic potential of the carotid plaque.2 In patients
with insufficient temporal acoustic windows, a short-
term monitoring may still be considered through the
transorbital window with minimal output power.
Identification and quantitative assessment of ‘high
risk’ plaque should be performed by morphological
evaluation with newer imaging techniques coupled
with emboli monitoring by PMD-TCD.
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Response to Letter to the Editor re: Identifying the
Carotid ’High Risk’ Plaque
I thank Sharma and colleagues for their letter. The in-
formation they provide on PMD-TCD is valuable. I
hope that PMD-TCD or some of the other new imag-
ing methods will prove to be of clinical value but as
stated in the article there is presently no irrefutable
evidence of this. The clinical problem of identifying
high risk asymptomatic carotid atheroma remains an
unanswered challenge at present.
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